transcept pharmaceuticals in
G. Kirk Raab
Lead Director, Member of Audit Committee and Member of Compensation Committee, Transcept Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 35 board members in 5 different organizations across 8 different industries.|
See Board Relationships
Mr. G. Kirk Raab served as the President and Chief Operating Officer of Genentech Inc. from February 1985 to 1990, and served as Genentech's President and Chief Executive Officer from January 1990 to July 1995. Mr. Raab served as an Interim Chief Executive Officer of LXR Biotechnology from April to August 1998. Mr. Raab served as an Acting Chief Executive Officer of BiPar Sciences Inc. from September 2007 to March 3, 2008. Prior to joining Genentech Inc., in 1985, Mr. ...
1003 West Cutting BoulevardPhone: 510-215-3500
Point Richmond, California 94804
Board Members Memberships*
Chairman of the Board
Chairman of the Board and Chairman of Compensation Committee
Former Chairman of the Board
Former Chairman of The Board, Chairman of Audit Committee and Member of Nominating & Corporate Governance Committee
Lead Director, Member of Audit Committee and Member of Compensation Committee
Annual Compensation*There is no Annual Compensation data available.
|Kevin C. Gorman Ph.D.||Chief Executive Officer, President and Director|
Neurocrine Biosciences Inc.
|Ian C. Read||Chairman, Chief Executive Officer and Chairman of Executive Committee|
|Christopher A. Viehbacher||Chief Executive Officer, Director and Member of Strategy Committee|
|Yasuchika Hasegawa||Chairman of the Board and Chief Executive Officer|
Takeda Pharmaceutical Company Limited
|Mihael H. Polymeropoulos M.D.||Founder, Chief Executive Officer, President and Director|
Vanda Pharmaceuticals, Inc.
|$515.0K||Compensation as of Fiscal Year 2013.|